Venofer 20 mg iron / ml

DRUG2 trials

Sponsors

Amag Pharmaceuticals Inc.

Conditions

Iron Deficiency Anemia (IDA)Iron Deficiency Anemia (IDA) in Pediatric Subjects with Chronic Kidney Disease (CKD)

Phase 3

A Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects

RecruitingCTIS2024-516264-28-00

Amag Pharmaceuticals Inc.Iron Deficiency Anemia (IDA)

Start: 2019-09-03Target: 51Updated: 2024-09-13

A Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatrics Subjects with Chronic Kidney Disease (CKD)

Active, not recruitingCTIS2024-516263-92-00

Amag Pharmaceuticals Inc.Iron Deficiency Anemia (IDA) in Pediatric Subjects with Chronic Kidney Disease (CKD)

Start: 2018-06-25Target: 25Updated: 2025-06-30